[{"orgOrder":0,"company":"Silvanols","sponsor":"University of Lorraine","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"","productType":"Small molecule","year":"2020","type":"Not Applicable","leadProduct":"Crocus Sativus","moa":"","graph1":"Neurology","graph2":"Approved","graph3":"Silvanols","amount2":0,"highestDevelopmentShortName":"Approved","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Capsule","sponsorNew":"Silvanols \/ University of Lorraine","highestDevelopmentStatusID":"12","companyTruncated":"Silvanols \/ University of Lorraine"}]

Find Clinical Drug Pipeline Developments & Deals for Ginseng Extract

Menu
Xls
Filters Filter
×
FILTER:
filter
Company Name
    filter

    Year

      filter

      DEALS // DEV.

        filter

        Country

          filter
          Sponsor
            filter

            Therapeutic Area

              filter

              Study Phase

                filter

                Deal Type

                  filter

                  Product Type

                    filter

                    Dosage Form

                      filter

                      Lead Product

                        filter

                        Target

                          Loading...

                          Therapeutic Area by Lead Product

                          Study Phase by Lead Product

                          Company by Lead Product

                          Top Deals by Deal Size (USD bn)

                          01

                          Details : GoRelax (lactium), specially patented cow’s milk protein split, has shown that this rotein improves sleep and is a natural anti-anxiety agent that helps reduce signs of stress.

                          Brand Name : GoRelax Day

                          Molecule Type : Small molecule

                          Upfront Cash : Not Applicable

                          March 26, 2020

                          Lead Product(s) : Lactium,Ginseng Extract,Crocus Sativus

                          Therapeutic Area : Neurology

                          Highest Development Status : Approved

                          Sponsor : University of Lorraine

                          Deal Size : Not Applicable

                          Deal Type : Not Applicable

                          Silvanols